Illumina appointed former NHGRI director Eric Green as chief medical officer, effective Feb. 2. Green leaves a long public‑sector tenure to join the sequencing leader as it seeks to accelerate clinical adoption of genomic tools and deepen hospital and health‑system engagement. Illumina said the hire fills a longstanding vacancy and will bolster the company’s strategy to expand comprehensive genomic profiling and clinical workflows. Green’s background at the NIH and his advisory roles position him to steer clinical translation and stakeholder engagement across payers and providers.